{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:57:12Z","timestamp":1778864232193,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["486308\/2013-8"],"award-info":[{"award-number":["486308\/2013-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s10875-022-01302-9","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T06:02:51Z","timestamp":1659160971000},"page":"1708-1720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Inborn Errors of Immunity in Patients with Adverse Events Following BCG Vaccination in Brazil"],"prefix":"10.1007","volume":"42","author":[{"given":"Paula T.","family":"Lyra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edvaldo","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Carla A.","family":"Moura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina C.","family":"Matta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leuridan C.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Victor Campos","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria \u00c2ngela W.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz","family":"Arraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Bosco","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"issue":"24","key":"1302_CR1","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1016\/j.vaccine.2018.03.009","volume":"36","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. BCG vaccine: WHO position paper, February 2018 \u2013 Recommendations. Vaccine. 2018;36(24):3408\u201310.","journal-title":"Vaccine"},{"key":"1302_CR2","unstructured":"World Health Organisation. (2018). Global tuberculosis report 2018. World Health Organisation. Available at: https:\/\/apps.who.int\/iris\/handle\/10665\/274453. Accessed 12 February 2020"},{"key":"1302_CR3","unstructured":"World Health Organisation. (2015). WHO | WHO End TB Strategy. World Health Organisation, 1-18. Available at: https:\/\/apps.who.int\/iris\/handle\/10665\/274453. Accessed 15 January 2020."},{"issue":"12","key":"1302_CR4","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/apa.13585","volume":"105","author":"G Boman","year":"2016","unstructured":"Boman G. The ongoing story of the Bacille Calmette-Gu\u00e9rin (BCG) vaccination. Acta Paediatr. 2016;105(12):1417\u201320.","journal-title":"Acta Paediatr"},{"key":"1302_CR5","doi-asserted-by":"crossref","unstructured":"Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011 Mar;8(3):e1001012.","DOI":"10.1371\/journal.pmed.1001012"},{"key":"1302_CR6","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade. Departamento de A\u00e7\u00f5es Progrm\u00e1ticas Estrat\u00e9gicas, B. (2019).Manual de para o Controle da Tuberculose. Minist\u00e9rio da Sa\u00fade (p.364). Minist\u00e9rio da Sa\u00fade. Available at https:\/\/www.aids.gov.br\/pt-br\/pub\/2019\/manual-de-recomendacoes-para-o-controle-da-tuberculose-no-brasil. Accessed 8 March 2020."},{"key":"1302_CR7","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia das Doen\u00e7as Transmiss\u00edveis.(2014).Manual de Vigil\u00e2ncia Epidemiol\u00f3gica de Eventos Adversos P\u00f3s-Vacina\u00e7\u00e3o. Minist\u00e9rio da Sa\u00fade (p.250). Available at: https:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/manual_vigilancia_epidemiologica_eventos_adversos_pos_vacinacao.pdf. Accessed 17 September 2019."},{"issue":"1","key":"1302_CR8","first-page":"84","volume":"58","author":"T das NevasFraga Moreira","year":"2016","unstructured":"das NevasFraga Moreira T, de Moraes-Pinto MI, Costa-Carvalho BT, Grumach AS, Weckx LY. Clinical management of localized bcg adverse events in children. Rev Inst Med Trop Sao Paulo. 2016;58(1):84.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"1","key":"1302_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5144\/0256-4947.2012.4","volume":"32","author":"AA Alrabiaah","year":"2012","unstructured":"Alrabiaah AA, Alsubaie SS, Bukhari EI, Gad A, Alzamel FA. Outbreak of Bacille Calmette-Gu\u00e9rin-related lymphadenitis in Saudi children at a university hospital after a change in the strain of vaccine. Ann Saudi Med. 2012;32(1):4\u20138.","journal-title":"Ann Saudi Med"},{"issue":"2","key":"1302_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4103\/0377-4929.97869","volume":"55","author":"E Bukhari","year":"2012","unstructured":"Bukhari E, Alzahrani M, Alsubaie S, Alrabiaah A, Alzamil F. Bacillus Calmette-Guerin lymphadenitis: a 6-year experience in two Saudi hospitals. Indian J Pathol Microbiol. 2012;55(2):202\u20135.","journal-title":"Indian J Pathol Microbiol"},{"key":"1302_CR11","unstructured":"Western Cape Department of Health. Intradermal BCG immunization: information for health workers about the use of intradermal BCG (bacille Calmette-Guerin) vaccine against tuberculosis in the Expanded Programme on Immunization in South Africa. Available at: https:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/manual_vigilancia_epidemiologica_eventos_adversos_pos_vacinacao.pdf. Accessed 5 July 2016."},{"key":"1302_CR12","first-page":"47","volume":"63","author":"A Lotte","year":"1988","unstructured":"Lotte A, Wasz-Hockert OPN, et al. Second IUATLD study on complications induced by intradermal BCG-vaccination. Bull Int Union Tuberc. 1988;63:47\u201359.","journal-title":"Bull Int Union Tuberc"},{"key":"1302_CR13","doi-asserted-by":"crossref","unstructured":"Hesseling AC, Rabie H, Marais BJ, Manders M, Lips M, Schaaf HS, et al. Bacille Calmette-Gu\u00e9rin vaccine \u2013 induced disease In HIV-infected and HIV-uninfected children. Clin Infect Dis. 2006 Feb 15;42(4):548\u201358.","DOI":"10.1086\/499953"},{"issue":"3","key":"1302_CR14","first-page":"202","volume":"6","author":"CMA Jacob","year":"1996","unstructured":"Jacob CMA, Pastorino AC, Azevedo AM, Marques HHS, Sato HK, Ferrazole L, et al. Mycobacterium bovis dissemination (BCG strain) among immunodeficient Brazilian infants. J Investig Allergol Clin Immunol. 1996;6(3):202\u20136.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"4","key":"1302_CR15","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.jaci.2014.02.028","volume":"133","author":"BE Marciano","year":"2014","unstructured":"Marciano BE, Huang CY, Joshi G, Rezaei N, Carvalho BC, Allwood Z, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol. 2014;133(4):1134\u201341.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1302_CR16","first-page":"184","volume":"24","author":"JTL Mazzucchelli","year":"2014","unstructured":"Mazzucchelli JTL, Bonfim C, Castro GG, Condino-Neto AA, Costa NMX, Cunha L, et al. Severe combined immunodeficiency in Brazil: management, prognosis, and BCG-associated complications. J Investig Allergol Clin Immunol. 2014;24(3):184\u201391.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"1","key":"1302_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jaci.2015.11.041","volume":"138","author":"F Conti","year":"2016","unstructured":"Conti F, Lugo-Reyes SO, Blancas Galicia L, He J, Aksu G, Borges de Oliveira E, et al. Mycobacterial disease in patients with chronic granulomatous disease: a\u00a0retrospective analysis of 71 cases. J Allergy Clin Immunol. 2016;138(1):241-248.e3.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1302_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jaci.2007.04.034","volume":"120","author":"J Bustamante","year":"2007","unstructured":"Bustamante J, Aksu G, Vogt G, de Beaucoudrey L, Genel F, Chapgier A, et al. BCG-osis and tuberculosis in a child with chronic granulomatous disease. J Allergy Clin Immunol. 2007;120(1):32\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"1302_CR19","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1002\/pbc.25674","volume":"62","author":"EB de Oliveira-Junior","year":"2015","unstructured":"de Oliveira-Junior EB, Zurro NB, Prando C, Cabral-Marques O, Pereira PVS, Schimke L-F, et al. Clinical and genotypic spectrum of chronic granulomatous disease in 71 Latin American patients: first report from the LASID Registry. Pediatr Blood Cancer. 2015;62(12):2101\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"1302_CR20","doi-asserted-by":"crossref","unstructured":"Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science (80- ). 1998;280(5368):1432\u20135.","DOI":"10.1126\/science.280.5368.1432"},{"issue":"11","key":"1302_CR21","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1172\/JCI2901","volume":"101","author":"SE Dorman","year":"1998","unstructured":"Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-\u03b3 receptor and susceptibility to mycobacterial infection. J Clin Invest. 1998;101(11):2364\u20139.","journal-title":"J Clin Invest"},{"issue":"7","key":"1302_CR22","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1084\/jem.20060085","volume":"203","author":"O Filipe-Santos","year":"2006","unstructured":"Filipe-Santos O, Bustamante J, Haverkamp MH, Vinolo E, Ku CL, Puel A, et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med. 2006;203(7):1745\u201359.","journal-title":"J Exp Med"},{"issue":"26","key":"1302_CR23","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1056\/NEJM199612263352604","volume":"335","author":"E Jouanguy","year":"1996","unstructured":"Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile J-F, Newport M, et al. Interferon-\u03b3 \u2013receptor deficiency in an infant with fatal Bacille Calmette-Gu\u00e9rin infection. N Engl J Med. 1996;335(26):1956\u201362.","journal-title":"N Engl J Med"},{"issue":"8974","key":"1302_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(95)91421-8","volume":"346","author":"JL Casanova","year":"1995","unstructured":"Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A. Immunological conditions of children with BCG disseminated infection. Lancet (London, England). 1995;346(8974):581.","journal-title":"Lancet (London, England)"},{"issue":"6","key":"1302_CR25","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1086\/513642","volume":"24","author":"EA Talbot","year":"1997","unstructured":"Talbot EA, Perkins MD, Silva SFM, Frothingham R. Disseminated Bacille Calmette-Guerin disease after vaccination: case report and review. Clin Infect Dis. 1997;24(6):1139\u201346.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1302_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/432119","volume":"41","author":"D de Moraes-Vasconcelos","year":"2005","unstructured":"de Moraes-Vasconcelos D, Grumach AS, Yamaguti A, Andrade MEB, Fieschi C, de Beaucoudrey L, et al. Paracoccidioides brasiliensis disseminated disease in a patient with inherited deficiency in the 1 subunit of the interleukin (IL)-12\/IL-23 receptor. Clin Infect Dis. 2005;41(4):31\u20137.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1302_CR27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1542\/peds.104.2.S1.397b","volume":"104","author":"SH Sicherer","year":"1999","unstructured":"Sicherer SH. Severe Mycobacterial and Salmonella infections in interleukin-12receptor-deficient patients. Pediatrics. 1999;104(2):397\u20138.","journal-title":"Pediatrics"},{"issue":"3","key":"1302_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1399-3038.2010.01084.x","volume":"22","author":"M Carneiro-Sampaio","year":"2011","unstructured":"Carneiro-Sampaio M, Jacob CMA, Leone CR. A proposal of warning signs for primary immunodeficiencies in the first year of life. Pediatr Allergy Immunol. 2011;22(3):345\u20136.","journal-title":"Pediatr Allergy Immunol"},{"issue":"5","key":"1302_CR29","first-page":"381","volume":"89","author":"L de Beaucoudrey","year":"2011","unstructured":"de Beaucoudrey L, Samarina A, Bustamante J, Abel L, Sanal O, Casanova J-L, et al. Revisiting humal IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries. Production. 2011;89(5):381\u2013402.","journal-title":"Production"},{"issue":"17","key":"1302_CR30","first-page":"3696","volume":"20","author":"E Bukhari","year":"2016","unstructured":"Bukhari E, Alaklobi F, Bakheet H, Alrabiaah A, Alotibi F, Aljobair F, et al. Disseminated bacille Calmette-Gu\u00e9rin disease in Saudi children: clinical profile, microbiology, immunology evaluation and outcome. Eur Rev Med Pharmacol Sci. 2016;20(17):3696\u2013702.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"1302_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-017-2499-7","volume":"10","author":"S Al-Hammadi","year":"2017","unstructured":"Al-Hammadi S, Alsuwaidi AR, Alshamsi ET, Ghatasheh GA, Souid AK. Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) infections in infants with immunodeficiency. BMC Res Notes. 2017;10(1):1\u20135.","journal-title":"BMC Res Notes"},{"issue":"3","key":"1302_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10875-019-0593-4","volume":"39","author":"SA Sarrafzadeh","year":"2019","unstructured":"Sarrafzadeh SA, Nourizadeh M, Mahloojirad M, Fazlollahi MR, ShokouhiShoormasti R, Badalzadeh M, et al. Molecular, immunological, and clinical features of 16 Iranian Patients with Mendelian susceptibility to Mycobacterial Disease. J Clin Immunol. 2019;39(3):287\u201397.","journal-title":"J Clin Immunol"},{"key":"1302_CR33","unstructured":"de Moraes-Pinto, MI; Ono, E. ; Antunes, E. ; Miyamoto, M. ; Dinelli, MIS. ; Santos-Valente, EC ; Almeida, LC. ; Costa-Carvalho, BT. ; Santos, AMN. ; Salom\u00e3o, R. . Lymphocyte subsets from birth through adulthood: values in a healthy Brazilian population and in patients under investigation for primary immunodeficiencies. In: Autoimmunity in Primary Immunodeficiencies. XII LAGID Meeting \/ I BRAGID Meeting, 2007, S\u00e3o Paulo. Clinics. S\u00e3o Paulo, 2007. v. 62. p. S54-S54."},{"issue":"4","key":"1302_CR34","first-page":"399","volume":"7","author":"I Dourado","year":"2003","unstructured":"Dourado I, Rios MH, Pereira SMM, Cunha SS, Ichihara MY, Goes JCL, et al. Rates of adverse reactions to first and second doses of BCG vaccination: results of a large community trial in Brazilian schoolchildren. Int J Tuberc Lung Dis. 2003;7(4):399\u2013402.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"1302_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0041-3879(83)90046-6","volume":"64","author":"GR de Souza","year":"1983","unstructured":"Muzy de Souza GR, Couto Sant\u2019Anna C, Lapa e Silva J, Biasotto Mano D, Manh\u00e3esBethlem N. Intradermal BCG vaccination complications\u2014 analysis of 51 cases. Tubercle. 1983;64(1):23\u20137.","journal-title":"Tubercle"},{"issue":"4","key":"1302_CR36","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/INF.0b013e3181fdff4a","volume":"30","author":"D Averbuch","year":"2011","unstructured":"Averbuch D, Chapgier A, Boisson-Dupuis S, Casanova J-L, Engelhard D. The clinical spectrum of patients with deficiency of signal transducer and activator of transcription-1. Pediatr Infect Dis J. 2011;30(4):352\u20135.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"1302_CR37","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.coi.2012.04.011","volume":"24","author":"S Boisson-Dupuis","year":"2012","unstructured":"Boisson-Dupuis S, Kong X-F, Okada S, Cypowyj S, Puel A, Abel L, et al. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr Opin Immunol. 2012;24(4):364\u201378.","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"1302_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/MD.0b013e31828a01f9","volume":"92","author":"C Prando","year":"2013","unstructured":"Prando C, Samarina A, Bustamante J, Boisson-Dupuis S, Cobat A, Picard C, et al. Inherited IL-12p40 deficiency. Medicine (Baltimore). 2013;92(2):109\u201322.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"1302_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10875-018-0527-6","volume":"38","author":"J Rosain","year":"2018","unstructured":"Rosain J, Oleaga-Quintas C, Deswarte C, Verdin H, Marot S, Syridou G, et al. A variety of alu-mediated copy number variations can underlie IL-12R\u03b21 deficiency. J Clin Immunol. 2018;38(5):617\u201327.","journal-title":"J Clin Immunol"},{"key":"1302_CR40","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3389\/fmicb.2017.00616","volume":"8","author":"T Louvain de Souza","year":"2017","unstructured":"Louvain de Souza T, de Souza Campos Fernandes RC, Azevedo da Silva J, Gomes Alves J\u00fanior V, Gomes Coelho A, Souza Faria AC, et al. Microbial disease spectrum linked to a novel IL-12R\u03b21 N-Terminal signal peptide stop-gain homozygous mutation with paradoxical receptor cell-surface expression. Front Microbiol. 2017;8:616.","journal-title":"Front Microbiol"},{"issue":"3","key":"1302_CR41","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/10408363.2018.1444580","volume":"55","author":"A Esteve-Sol\u00e9","year":"2018","unstructured":"Esteve-Sol\u00e9 A, Sologuren I, Mart\u00ednez-Saavedra MT, Dey\u00e0-Mart\u00ednez \u00c0, Oleaga-Quintas C, Martinez-Barricarte R, et al. Laboratory evaluation of the IFN-\u03b3 circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease. Crit Rev Clin Lab Sci. 2018 Apr 3;55(3):184\u2013204.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"1302_CR42","first-page":"83","volume":"15","author":"Z Movahedi","year":"2011","unstructured":"Movahedi Z, Norouzi S, Mamishi S, Rezaei N. BCGiosis as a presenting feature of a child with chronic granulomatous disease. Brazilian J Infect Dis. 2011;15(1):83\u20136.","journal-title":"Brazilian J Infect Dis"},{"issue":"3","key":"1302_CR43","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s10875-018-0486-y","volume":"38","author":"Q Zhou","year":"2018","unstructured":"Zhou Q, Hui X, Ying W, Hou J, Wang W, Liu D, et al. A cohort of 169 Chronic granulomatous disease patients exposed to BCG vaccination: a retrospective Study from a single center in Shanghai, China (2004\u20132017). J Clin Immunol. 2018;38(3):260\u201372.","journal-title":"J Clin Immunol"},{"key":"1302_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1824-7288-35-42","volume":"35","author":"M Sadeghi-Shanbestari","year":"2009","unstructured":"Sadeghi-Shanbestari M, Ansarin K, Maljaei SH, Rafeey M, Pezeshki Z, Kousha A, et al. Immunologic aspects of patients with disseminated bacille Calmette-Guerin disease in north-west of Iran. Ital J Pediatr. 2009;35:42.","journal-title":"Ital J Pediatr"},{"issue":"4","key":"1302_CR45","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.aller.2016.10.006","volume":"45","author":"MR Bolursaz","year":"2017","unstructured":"Bolursaz MR, Lotfian F, Velayati AA. Bacillus Calmette-Gu\u00e9rin vaccine complications in Iranian children at a University Hospital. Allergol Immunopathol (Madr). 2017;45(4):356\u201361.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"4","key":"1302_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0094485","volume":"9","author":"W Ying","year":"2014","unstructured":"Ying W, Sun J, Liu D, Hui X, Yu Y, Wang J, et al. Clinical characteristics and immunogenetics of BCGosis\/BCGitis in Chinese children: a 6 year follow-up study. PLoS ONE. 2014;9(4):1\u20136.","journal-title":"PLoS ONE"},{"key":"1302_CR47","unstructured":"For Immunodeficiency BG. Os 10 sinais de alerta para imunodefici\u00eanica prim\u00e1ria na crian\u00e7a adaptados [Internet]. [cited 2020 Feb 28]. Available from: www.imunopediatria.org.br"},{"issue":"11","key":"1302_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/jjm.25663","volume":"8","author":"MH Aelami","year":"2015","unstructured":"Aelami MH, Alborzi A, Pouladfar G, Geramizadeh B, Pourabbas B, Mardaneh J. Post-vaccination disseminated bacillus calmette guerin infection among children in southern Iran. Jundishapur J Microbiol. 2015;8(11):1\u20137.","journal-title":"Jundishapur J Microbiol"},{"issue":"3","key":"1302_CR49","first-page":"133","volume":"5","author":"SA Paiman","year":"2006","unstructured":"Paiman SA, Siadati A, Mamishi S, Tabatabaie P, Khotaee G. Disseminated Mycobacterium bovis infection after BCG vaccination. Iran J Allergy Asthma Immunol. 2006;5(3):133\u20137.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"3","key":"1302_CR50","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.aller.2014.01.003","volume":"43","author":"P Sharifi Asadi","year":"2015","unstructured":"Sharifi Asadi P, Aghamohammadi A, Mahmoudi S, Pourakbari B, Saboui F, Mamishi S. Clinical, laboratory and imaging findings of the patients with disseminated bacilli Calmette-Guerin disease. Allergol Immunopathol (Madr). 2015;43(3):254\u20138.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"52","key":"1302_CR51","first-page":"1","volume":"96","author":"A Amanati","year":"2017","unstructured":"Amanati A, Pouladfar G, Kadivar MR, SanaeiDashti A, Jafarpour Z, Haghpanah S, et al. A 25-year surveillance of disseminated Bacillus Calmette-Gu\u00e9rin disease treatment in children in Southern Iran. Med (United States). 2017;96(52):1\u20135.","journal-title":"Med (United States)"},{"issue":"1","key":"1302_CR52","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4103\/ijd.IJD_327_17","volume":"63","author":"K Sellami","year":"2018","unstructured":"Sellami K, Amouri M, Kmiha S, Bahloul E, Aloulou H, Sfaihi L, et al. Adverse Reactions Due to the Bacillus Calmette-Guerin Vaccine: Twenty Tunisian Cases. Indian J Dermatol. 2018;63(1):62\u20135.","journal-title":"Indian J Dermatol."},{"key":"1302_CR53","first-page":"8","volume":"12","author":"ADW Luk","year":"2017","unstructured":"Luk ADW, Lee PP, Mao H, Chan K-W, Chen XY, Chen T-X, et al. Family history of early infant death correlates with earlier age at diagnosis but not shorter time to diagnosis for severe combined immunodeficiency. Front Immunol. 2017;12:8.","journal-title":"Front Immunol"},{"issue":"4","key":"1302_CR54","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jaip.2015.01.026","volume":"3","author":"LM McWilliams","year":"2015","unstructured":"McWilliams LM, Dell Railey M, Buckley RH. Positive family history, infection, low absolute lymphocyte count (ALC), and absent thymic shadow: diagnostic clues for all molecular forms of severe combined immunodeficiency (SCID). J Allergy Clin Immunol Pract. 2015;3(4):585\u201391.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"1302_CR55","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1824-7288-39-54","volume":"39","author":"P Roxo-Junior","year":"2013","unstructured":"Roxo-Junior P, Silva J, Andrea M, Oliveira L, Ramalho F, Bezerra T, et al. A family history of serious complications due to BCG vaccination is a tool for the early diagnosis of severe primary immunodeficiency. Ital J Pediatr. 2013;39(1):2\u20135.","journal-title":"Ital J Pediatr"},{"issue":"4","key":"1302_CR56","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/imcb.12210","volume":"97","author":"J Rosain","year":"2019","unstructured":"Rosain J, Kong XF, Martinez-Barricarte R, Oleaga-Quintas C, Ramirez-Alejo N, Markle J, et al. Mendelian susceptibility to mycobacterial disease: 2014\u20132018 update. Immunol Cell Biol. 2019;97(4):360\u20137.","journal-title":"Immunol Cell Biol"},{"issue":"6","key":"1302_CR57","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","volume":"26","author":"J Bustamante","year":"2014","unstructured":"Bustamante J, Boisson-Dupuis S, Abel L, Casanova J-L. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity. Semin Immunol. 2014;26(6):454\u201370.","journal-title":"Semin Immunol"},{"issue":"4","key":"1302_CR58","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jaip.2020.01.038","volume":"8","author":"S Fekrvand","year":"2020","unstructured":"Fekrvand S, Yazdani R, Olbrich P, Gennery A. Primary immunodeficiency diseases and Bacillus Calmette-Gu\u00e9rin ( BCG ) -vaccine e derived complications\u202f: a systematic review. J Allergy Clin Immunol Pract. 2020;8(4):1371\u201386.","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01302-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01302-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01302-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T22:43:08Z","timestamp":1669416188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-022-01302-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1302"],"URL":"https:\/\/doi.org\/10.1007\/s10875-022-01302-9","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]},"assertion":[{"value":"7 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adheres to the Declaration of Helsinki principles for research in human beings and was approved by the Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)\u2019s Committee of Ethics in Research (ethics approval number: CAAE 11841312.0.0000.5201).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was obtained from all patients and\/or their parents or legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Written informed consent for publication of clinical details were obtained from all patients and\/or their parents or legal guardians.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}